Variant report
Variant | esv16984 |
---|---|
Chromosome Location | chr17:33705204-33716191 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:7)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:7 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr17:33715403-33715497 | Lung_OC | lung: | n/a | n/a |
2 | CTCF | chr17:33714500-33714616 | Kidney_OC | kidney: | n/a | n/a |
3 | CTCF | chr17:33710084-33710105 | GM10266 | blood: | n/a | n/a |
4 | GATA3 | chr17:33711369-33711687 | T-47D | breast: | n/a | n/a |
5 | GATA3 | chr17:33711454-33711645 | T-47D | breast: | n/a | n/a |
6 | SPI1 | chr17:33707082-33707230 | K562 | blood: | n/a | n/a |
7 | STAT3 | chr17:33715394-33715623 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
SLFN11 | TF binding region |
ENSG00000267315 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs533646415 | chr17:33705235-33705236 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs550366252 | chr17:33705242-33705243 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs567162914 | chr17:33705249-33705250 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs71381434 | chr17:33705250-33705251 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs36071872 | chr17:33705273-33705274 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs564873018 | chr17:33705298-33705299 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs116006660 | chr17:33705342-33705343 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs34777220 | chr17:33705358-33705359 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs111485470 | chr17:33705364-33705365 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs578145933 | chr17:33705377-33705378 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs181673913 | chr17:33705383-33705384 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs185747508 | chr17:33705398-33705399 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs188842868 | chr17:33705403-33705404 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs181279028 | chr17:33705454-33705455 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs149079052 | chr17:33705460-33705461 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs34027158 | chr17:33705467-33705468 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs9972970 | chr17:33705468-33705469 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
18 | rs374884296 | chr17:33705470-33705471 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs370815484 | chr17:33705479-33705480 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs546848476 | chr17:33705506-33705507 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs185433398 | chr17:33705510-33705511 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs553788592 | chr17:33705533-33705534 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs150794826 | chr17:33705556-33705557 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs551368516 | chr17:33705616-33705617 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs567981838 | chr17:33705618-33705619 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs189786723 | chr17:33705620-33705621 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs550292950 | chr17:33705624-33705625 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs62080983 | chr17:33705633-33705634 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs557955221 | chr17:33705638-33705639 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs536465747 | chr17:33705691-33705692 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs148326996 | chr17:33705759-33705760 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs371816668 | chr17:33705825-33705826 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs555863839 | chr17:33705867-33705868 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs547423098 | chr17:33705889-33705890 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs117058836 | chr17:33705941-33705942 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs140519034 | chr17:33705949-33705950 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs145635610 | chr17:33706001-33706002 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs183948634 | chr17:33706054-33706055 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs537427478 | chr17:33706079-33706080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs557518513 | chr17:33706149-33706150 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs574154430 | chr17:33706186-33706187 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs376114765 | chr17:33706259-33706260 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs543225420 | chr17:33706265-33706266 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs372199182 | chr17:33706266-33706267 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs553252733 | chr17:33706276-33706277 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs368345702 | chr17:33706281-33706282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs573487030 | chr17:33706298-33706299 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs542109453 | chr17:33706304-33706305 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs28827270 | chr17:33706314-33706315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs373379224 | chr17:33706333-33706334 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Moyamoya disease | 22323933 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Cancer | 20164919 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 17603634 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Cancer | 16751803 | CNVD |
Chordoma | 21602918 | CNVD |
Neurofibromatosis | 20686819 | CNVD |
Peripheral nerve sheath tumors | 20686819 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Breast cancer | 21264507 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 16397240 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 17001317 | CNVD |
Breast cancer | 17157792 | CNVD |
Bladder cancer | 19088036 | CNVD |
Gastric cancer | 17167181 | CNVD |
Breast cancer | 19287154 | CNVD |
Leukemia | 20874852 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Meningioma | 19431122 | CNVD |
Neurocytoma | 17123091 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Lung cancer | 21911935 | CNVD |
Breast cancer | 22048815 | CNVD |
Cervical cancer | 21062161 | CNVD |
Colorectal cancer | 22860045 | CNVD |
Ductal carcinoma | 18381933 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16417655 | CNVD |
Renal cysts | 20603712 | CNVD |
Epilepsy | 21858020 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Autism | 20587423 | CNVD |
Renal cysts | 20587423 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Mayer-Rokitansky-Kuster-Hauser syndrome | 19889212 | CNVD |
Endometrial cancer | 23636398 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Gastric cancer | 24379144 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Gastric cancer | 18160780 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Breast cancer | 17850661 | CNVD |
Primary lung adenocarcinoma | 16799635 | CNVD |
HIV/AIDS | 18848619 | CNVD |
Rheumatoid arthritis | 19220326 | CNVD |
Rheumatoid arthritis | 18848619 | CNVD |
Systemic lupus erythematosus | 19220326 | CNVD |
Systemic lupus erythematosus | 18848619 | CNVD |
Type 1 diabetes | 19220326 | CNVD |
HIV/AIDS | 17330138 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Autism | 19955444 | CNVD |
Schizophrenia | 19955444 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Breast cancer | 20409316 | CNVD |
Myelodysplastic syndrome | 18663149 | CNVD |
Breast cancer | 17457667 | CNVD |
Breast cancer | 16951389 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Lung cancer | 19153074 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 20932292 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:33702000-33706000 | Enhancers | Primary monocytes fromperipheralblood | blood |
2 | chr17:33702200-33707000 | Weak transcription | Primary B cells from peripheral blood | blood |
3 | chr17:33704800-33705800 | Weak transcription | Colon Smooth Muscle | Colon |
4 | chr17:33705200-33705800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
5 | chr17:33705800-33706000 | Enhancers | Colon Smooth Muscle | Colon |
6 | chr17:33705800-33708200 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
7 | chr17:33706000-33707000 | Weak transcription | Primary monocytes fromperipheralblood | blood |
8 | chr17:33707000-33707400 | Enhancers | Primary B cells from peripheral blood | blood |
9 | chr17:33707000-33709600 | Enhancers | Primary monocytes fromperipheralblood | blood |
10 | chr17:33707400-33708200 | Weak transcription | Primary B cells from peripheral blood | blood |
11 | chr17:33708200-33709400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
12 | chr17:33708200-33709600 | Enhancers | Primary B cells from peripheral blood | blood |
13 | chr17:33708600-33709400 | Enhancers | Primary B cells from cord blood | blood |
14 | chr17:33708800-33709200 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
15 | chr17:33716000-33717200 | Enhancers | Monocytes-CD14+_RO01746 | blood |